Clinical evaluation indices for hemodialysis/hemodiafiltration in Japan

Contributions to Nephrology

Volumn 168, Issue , 2011, Pages 173-178

  Shinoda, Toshio ^a   Koda, Yutaka ^b  

^a Kawakita General Hospital   (Japan)

^b Koda Medical and Dialysis Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL MEMBRANE; CHRONIC KIDNEY FAILURE; HEMODIAFILTRATION; HUMAN; INSTRUMENTATION; JAPAN; MORTALITY; PREVALENCE; RENAL REPLACEMENT THERAPY; STATISTICS; SURVIVAL RATE;

HEMODIAFILTRATION; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; PREVALENCE; RENAL DIALYSIS; SURVIVAL RATE;

EID: 78249268285     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000321758     Document Type: Article

References (16)

1. Nakai S, Masakane I, Shigematsu T, et al: An overview of regular dialysis treatment in Japan (as of 31 December 2007). Ther Aper Dial 2009;13:457-504.
2. Held PJ, Akiba T, Atearns NS, et al: Survival of middle-aged dialysis patients in Japan and the USA, 1988-89; in Friedman EA, et al (eds): Developments in Nephrology, vol 35: Death on Hemodialysis. Dordrecht, Kluwer Academic, 1994, pp 13-23.
3. Akiba T, Akisawa T, Fukuhara S, et al: Results of the international DOPPS hemodialysis study in Japan. J Jpn Soc Dial Ther 2004;37:1865-1873.
4. The Japanese Society for Clinical Renal Transplantation and the Japanese Society for Transplantation: Annual progress report from the Japanese Renal Transplantation Registry, the number of renal transplantations in 2007. Jpn J Transplant 2008;43:206-210.
5. Quellhorst E, Doht B, Schuenemann B: Hemofiltration: treatment of renal failure by ultrafiltration and substitution. J Dial 1977;1:529-543. (Pubitemid 8201361)
6. Schaldon S, Deschodt G, Branger B, et al: Hemodialysis hypotension: the interleukin hypothesis restated. Proc Eur Dial Transplant Assoc 1985;22:229-243.
7. Canaud B, Bragg-Gresham JL, Marshall MR, et al: Mortality risk for receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 2006;69:2087-2093.
8. Hakim RM, Held PJ, Stannard DC, et al: Effect of dialytic membrane on mortality of chronic hemodialysis patients. Kidney Int 1996;50:566-570.
9. Koda Y, Nishi S, Miyazaki S, et al: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997;52:1096-1101.
10. Eknoyan G, Beck GJ, Cheung AK, et al: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-2019.
11. Cheung AK, Levin NW, Greene T, et al: Effect of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003;14:3251-3263.
12. Movilli E, Camerini C, Zein H, et al: A prospective comparison of bicarbonate dialysis, hemodiafiltration, and acetate-free biofiltration in the elderly. Am J Kidney Dis 1996;27:541-547.
13. Nakai S, Iseki K, Tabei K, et al: Outcome of hemodiafiltration based on Japanese Dialysis Patient Registry. Am J Kidney Dis 2001;38(suppl 1):212-216.
14. Maduell F, Navarro V, Cruz MC, et al: Osteocalcin and myoglobulin removal in online hemodiafiltration versus low- and high-flux hemodialysis. Am J Kidney Dis 2002;40:582-589.
15. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Removal of protein-bound solute p-cresol by convective transport: a randomized crossover study. Am J Kidney Dis 2004;44:278-285.
16. Guth HJ, Gruska S, Kraatz G: Online production of ultrapure substitution fluid reduces TNF-α- and IL-6 release in patients on hemodiafiltration therapy. Int J Artif Organs 2003;26:181-187.